Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Project V - A Randomized Controlled Prospective Study of the Next-generation Probiotic, Veillonella Atypica FB0054, vs Placebo in Healthy Adults

NCT06141343 is registered in ClinicalTrials.gov with FitBiomics, Inc. as lead sponsor.

NCT NCT06141343
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06141343 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Project V - A Randomized Controlled Prospective Study of the Next-generation Probiotic, Veillonella Atypica FB0054, vs Placebo in Healthy Adults
Lead sponsor
FitBiomics, Inc.
Phase
Observational
Overall status
Completed
Start date
August 1, 2023
Completion date
November 7, 2023
Enrollment
153 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatigue